DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Impact of CRISP on Self-Efficacy, Loneliness, and Depression

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Other: Control Group
Behavioral: CRISP Program

First Posted Date: 2014-01-08

Last Posted Date: 2014-12-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 118

Registration Number: NCT02030197

Locations: 🇺🇸
NYU MS Center, New York, New York, United States

Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Procedure: Ultrasound Imaging

First Posted Date: 2013-12-31

Last Posted Date: 2016-06-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 34

Registration Number: NCT02024178

Locations: 🇺🇸
Smilow Comprehensive Prostate Cancer Center, New York, New York, United States

Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program

Not Applicable

Completed

Conditions: Lung Diseases
Medication Compliance

Interventions: Drug: Fluticasone propionate 230mcg for 3 Months
Drug: Current Treatment or no treatment
Drug: Salmeterol 21mcg for 3 Months

First Posted Date: 2013-12-31

Last Posted Date: 2021-02-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT02024204

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors

Not Applicable

Completed

Conditions: Hypertension
Stroke

Interventions: Behavioral: Home BP Telemonitoring (HBPTM)
Behavioral: Nurse Case Management (NCM)

First Posted Date: 2013-12-13

Last Posted Date: 2022-02-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 450

Registration Number: NCT02011685

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry

Phase 4

Completed

Conditions: Heroin Dependence
Opioid-Related Disorders

Interventions: Drug: Extended-Release Naltrexone

First Posted Date: 2013-12-03

Last Posted Date: 2021-06-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 217

Registration Number: NCT01999946

Locations: 🇺🇸
NYC Department of Corrections: Rikers Island Jail Facilities, New York, New York, United States
🇺🇸
Bellevue Hospital Center, New York, New York, United States

Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome

Not Applicable

Terminated

Conditions: Medical Knowledge
Clinical Performance

Interventions: Other: Debriefing of high-fidelity sepsis simulation scenarios

First Posted Date: 2013-11-25

Last Posted Date: 2015-12-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT01992120

Locations: 🇺🇸
VA Harbor Simulation Center, New York, New York, United States

Evaluating for Type-2 Diabetes in the Very Early Postpartum Period

Completed

Conditions: Diabetes, Gestational
Prediabetic State
Glucose Metabolism Disorders
Diabetes Mellitus

Interventions: Other: Inpatient Postpartum GTT

First Posted Date: 2013-11-20

Last Posted Date: 2020-01-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 123

Registration Number: NCT01988987

Locations: 🇺🇸
NYU Winthrop Hospital, Mineola, New York, United States

The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia

Phase 3

Completed

Conditions: Familial Dysautonomia

Interventions: Drug: Ipratropium-bromide
Other: placebo
Drug: Albuterol-sulphate

First Posted Date: 2013-11-19

Last Posted Date: 2016-06-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT01987219

Locations: 🇺🇸
NYU Medical Center, New York, New York, United States

ISCHEMIA-Chronic Kidney Disease Trial

Phase 4

Completed

Conditions: Heart Diseases
Kidney Disease
End Stage Renal Failure on Dialysis
Cardiovascular Diseases
Coronary Artery Disease
Myocardial Ischemia

Interventions: Procedure: Cardiac Catheterization
Procedure: Coronary Artery Bypass Graft Surgery
Procedure: Percutaneous Coronary Intervention
Behavioral: Lifestyle
Drug: Medication

First Posted Date: 2013-11-15

Last Posted Date: 2021-10-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 777

Registration Number: NCT01985360

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

Phase 4

Completed

Conditions: Delusional Disorder
Schizophrenia
Schizoaffective Disorder

Interventions: Other: Placebo
Drug: D-Cycloserine
Behavioral: Cognitive Behavioral Therapy

First Posted Date: 2013-11-13

Last Posted Date: 2020-03-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 58

Registration Number: NCT01981759

Locations: 🇺🇸
Sheppard Pratt, Baltimore, Maryland, United States
🇺🇸
New York Langone Medical Center/Bellevue Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy